Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis

References

• Adams, B. D., A. L. Kasinski, and F. J. Slack. 2014. Aberrant regulation and function of microRNAs in cancer. Curr. Biol. 24:R762–R776. doi:10.1016/j.cub.2014.06.043.
   PubMed Web of Science ®Google Scholar
• Ayuk, S. M., and H. Abrahamse. 2019. mTOR signaling pathway in cancer targets photodynamic therapy in vitro. Cells 8:E431. doi:10.3390/cells8020137.
   PubMed Web of Science ®Google Scholar
• Berezikov, E. 2011. Evolution of microRNA diversity and regulation in animals. Nat. Rev. Genet. 12:846–60. doi:10.1038/nrg3079.
   PubMed Web of Science ®Google Scholar
• Bertoli, G., C. Cava, and I. Castiglioni. 2015. MicroRNAs: New biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 5:1122–43. doi:10.7150/thno.11543.
   PubMed Web of Science ®Google Scholar
• Bjaanaes, M. M., A. R. Halvorsen, S. Solberg, L. Jorgensen, T. A. Dragani, A. Galvan, F. Colombo, M. Anderlini, U. Pastorino, E. Kure, et al. 2014. Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. Int. J. Cancer 135:1812–21. doi:10.1002/ijc.28828.
   PubMed Web of Science ®Google Scholar
• Boll, K., K. Reiche, K. Kasack, N. Morbt, A. K. Kretzschmar, J. M. Tomm, G. Verhaegh, J. Schalken, M. von Bergen, F. Horn, et al. 2013. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 32:277–85. doi:10.1038/onc.2012.55.
   PubMed Web of Science ®Google Scholar
• Brock, M. V., C. M. Hooker, E. Ota-Machida, Y. Han, M. Guo, S. Ames, S. Glockner, S. Piantadosi, E. Gabrielson, G. Pridham, et al. 2008. DNA methylation markers and early recurrence in stage I lung cancer. N. Engl. J. Med. 358:1118–28. doi:10.1056/NEJMoa0706550.
   PubMed Web of Science ®Google Scholar
• Cekaite, L., P. W. Eide, G. E. Lind, R. I. Skotheim, and R. A. Lothe. 2016. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget 7:6476–505. doi:10.18632/oncotarget.6390.
   PubMedGoogle Scholar
• Centers for Disease, Control and Prevention (CDC). 2010. Racial disparities in smoking-attributable mortality and years of potential life lost — Missouri, 2003–2007. Morb. Mortal Weekly Rep. 59: 1518–22.
   PubMedGoogle Scholar
• Chen, H., Y. Yang, J. Wang, D. Shen, J. Zhao, and Q. Yu. 2018. miR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1. Oncol. Lett. 15:6361–67. doi:10.3892/ol.2018.8174.
   PubMed Web of Science ®Google Scholar
• Chen, J. S., D. D. Yan, W. L. Wu, J. Zhu, W. S. Ye, and Q. Shu. 2016. MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN. Oncol. Rep. 35:3285–92. doi:10.3892/or.2016.4719.
   PubMed Web of Science ®Google Scholar
• Chen, Y. L., C. J. Ko, P. Y. Lin, W. L. Chuang, C. C. Hsu, P. Y. Chu, M. Y. Pai, C. C. Chang, M. H. Kuo, Y. R. Chu, et al. 2012. Clustered DNA methylation changes in polycomb target genes in early-stage liver cancer. Biochem. Biophys. Res. Commun. 425:290–96. doi:10.1016/j.bbrc.2012.07.084.
   PubMed Web of Science ®Google Scholar
• Colangelo, T., A. Fucci, C. Votino, L. Sabatino, M. Pancione, C. Laudanna, M. Binaschi, M. Bigioni, C. A. Maggi, D. Parente, et al. 2013. MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer. Neoplasia 15:1204–17. doi:10.1593/neo.13998.
   Web of Science ®Google Scholar
• Cui, X., C. Kong, Y. Zhu, Y. Zeng, Z. Zhang, X. Liu, B. Zhan, C. Piao, and Z. Jiang. 2016. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing cylindromatosis expression. Oncotarget 7:48547–61. doi:10.18632/oncotarget.10423.
   PubMedGoogle Scholar
• Damps, I., E. Jassem, and A. Sieminska. 2001. Molecular basis of carcinogenesis in lung cancer induced by cigarette smoking. Pol. Merkur Lekarski 10:403–04.
   PubMedGoogle Scholar
• Ellisen, L. W. 2017. A wound-healing program is hijacked to promote cancer metastasis. J. Exp. Med. 214:2813–15. doi:10.1084/jem.20171556.
   PubMed Web of Science ®Google Scholar
• Gyorffy, B., G. Bottai, T. Fleischer, G. Munkacsy, J. Budczies, L. Paladini, A. L. Borresen-Dale, V. N. Kristensen, and L. Santarpia. 2016. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes. Int. J. Cancer 138:87–97. doi:10.1002/ijc.29684.
   PubMed Web of Science ®Google Scholar
• Ha, M., . J., and V., . N. Kim. 2014. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15:509–24. doi:10.1038/nrm3838.
   PubMed Web of Science ®Google Scholar
• Hashimoto, Y., M. Shiina, P. Dasgupta, P. Kulkarni, T. Kato, R. K. Wong, Y. Tanaka, V. Shahryari, S. Maekawa, S. Yamamura, et al. 2019. Upregulation of miR-130b contributes to risk of poor prognosis and racial disparity in African-American prostate cancer. Cancer Prev Res 12:585–98. doi:10.1158/1940-6207.CAPR-18-0509.
   PubMed Web of Science ®Google Scholar
• Hayes, C. N., and K. Chayama. 2016. MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int. J. Mol. Sci. 17:280. doi:10.3390/ijms17030280.
   PubMed Web of Science ®Google Scholar
• He, L., H. Y. Wang, L. Zhang, L. Huang, J. D. Li, Y. Xiong, M. Y. Zhang, W. H. Jia, J. P. Yun, R. Z. Luo, et al. 2014. Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer. Cell Death Dis. 5:e1205. doi:10.1038/cddis.2014.127.
   PubMed Web of Science ®Google Scholar
• Heller, G., C. Altenberger, I. Steiner, T. Topakian, B. Ziegler, E. Tomasich, G. Lang, A. End-Pfutzenreuter, S. Zehetmayer, B. Dome, et al. 2018. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients. J. Pathol. 245:387–98. doi:10.1002/path.5079.
   PubMed Web of Science ®Google Scholar
• Hirono, T., K. Jingushi, T. Nagata, M. Sato, K. Minami, M. Aoki, A. H. Takeda, T. Umehara, H. Egawa, Y. Nakatsujil, et al. 2019. MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2. Sci. Rep. 9:6956. doi:10.1038/s41598-019-43355-8.
   PubMed Web of Science ®Google Scholar
• Hoque, M. O. 2009. DNA methylation changes in prostate cancer: Current developments and future clinical implementation. Expert Rev. Mol. Diagn. 9:243–57. doi:10.1586/erm.09.10.
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to. 2004. Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog Risks Human 83: 1–1438.
   PubMedGoogle Scholar
• Jiang, H., W. W. Yu, L. L. Wang, and Y. Peng. 2015. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol. Rep. 34:1153–61. doi:10.3892/or.2015.4099.
   PubMed Web of Science ®Google Scholar
• Jin, Y., Y. L. Liu, J. Zhang, W. Huang, H. N. Jiang, Y. Y. Hou, C. Xu, C. W. Zhai, X. Gao, S. Y. Wang, et al. 2015. The expression of miR-375 Is Associated with carcinogenesis in three subtypes of lung cancer. Plos One 10:e0144187. doi:10.1371/journal.pone.0144187.
   PubMedGoogle Scholar
• Kunej, T., I. Godnic, J. Ferdin, S. Horvat, P. Dovc, and G. A. Calin. 2011. Epigenetic regulation of microRNAs in cancer: An integrated review of literature. Mutat. Res. 717:77–84. doi:10.1016/j.mrfmmm.2011.03.008.
   PubMed Web of Science ®Google Scholar
• Lai, K. W., K. X. Koh, M. Loh, K. Tada, M. M. Subramaniam, X. Y. Lim, A. Vaithilingam, M. Salto-Tellez, B. Iacopetta, Y. Ito, Singapore Gastric Canc Consortium, et al. 2010. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer Eur. J. Cancer 46: 1456–63. doi: 10.1016/j.ejca.2010.01.036.
   PubMed Web of Science ®Google Scholar
• Liang, Y. Y., J. C. Huang, R. X. Tang, W. J. Chen, P. Chen, W. L. Cen, K. Shi, L. Gao, X. Gao, A. G. Liu, et al. 2018. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. World J. Surg. Oncol. 16:22. doi:10.1186/s12957-018-1320-y.
   PubMed Web of Science ®Google Scholar
• Liu, X., C. Kong, and Z. Zhang. 2018. miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4. Oncol. Rep. 39:2324–32. doi:10.3892/or.2018.6300.
   PubMed Web of Science ®Google Scholar
• Lopez-Serra, P., and M. Esteller. 2012. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31:1609–22. doi:10.1038/onc.2011.354.
   PubMed Web of Science ®Google Scholar
• Lozano, R., M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S. Y. Ahn, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–128. doi:10.1016/S0140-6736(12)61728-0.
   PubMed Web of Science ®Google Scholar
• Martin, H. C., S. Wani, A. L. Steptoe, K. Krishnan, K. Nones, E. Nourbakhsh, A. Vlassov, S. M. Grimmond, and N. Cloonan. 2014. Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs. Genome. Biol. 15:R51. doi:10.1186/gb-2014-15-3-r51.
   PubMed Web of Science ®Google Scholar
• Miao, Y., W. Zheng, N. Li, Z. Su, L. Zhao, H. Zhou, and L. Jia. 2017. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway. Sci. Rep. 7:41942. doi:10.1038/srep41942.
   PubMed Web of Science ®Google Scholar
• Pavel, A. B., J. D. Campbell, G. Liu, D. Elashoff, S. Dubinett, K. Smith, D. Whitney, M. E. Lenburg, A. Spira, and A. S. Team. 2017. Alterations in bronchial airway miRNA expression for lung cancer detection. Cancer Prev. Res. 10:651–59. doi:10.1158/1940-6207.CAPR-17-0098.
   PubMed Web of Science ®Google Scholar
• Ramalho-Carvalho, J., I. Graça, A. Gomez, J. Oliveira, R. Henrique, M. Esteller, and C. Jerónimo. 2017. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. J. Hematol. Oncol. 10:43. doi:10.1186/s13045-017-0415-1.
   PubMed Web of Science ®Google Scholar
• Ratert, N., H. A. Meyer, M. Jung, P. Lioudmer, H. J. Mollenkopf, I. Wagner, K. Miller, E. Kilic, A. Erbersdobler, S. Weikert, et al. 2013. miRNA profiling identifies candidate miRNAs for bladder cancer diagnosis and clinical outcome. J. Mol. Diagn. 15:695–705. doi:10.1016/j.jmoldx.2013.05.008.
   PubMed Web of Science ®Google Scholar
• Santarpia, L., S. M. Lippman, and A. K. El-Naggar. 2012. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin. Ther. Targets 16:103–19. doi:10.1517/14728222.2011.645805.
   PubMed Web of Science ®Google Scholar
• Shivakumar, M., Y. Lee, L. S. Bang, T. Garg, K. A. Sohn, and D. Kim. 2017. Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer. BMC Med. Genomics 10:30. doi:10.1186/s12920-017-0269-y.
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., K. D. Miller, and A. Jemal. 2018. Cancer statistics, 2018. CA Cancer J. Clin. 68:7–30. doi:10.3322/caac.21442.
   PubMed Web of Science ®Google Scholar
• Singh, D. K., S. Bose, and S. Kumar. 2016. Regulation of expression of microRNAs by DNA methylation in lung cancer. Biomarkers 21:589–99. doi:10.3109/1354750X.2016.1171906.
   PubMed Web of Science ®Google Scholar
• Sundar, I. K., K. Rashid, J. Gerloff, J. Rangel-Moreno, D. Li, and I. Rahman. 2018. Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema. Faseb. J. 32:4955–71. doi:10.1096/fj.201701518R.
   PubMed Web of Science ®Google Scholar
• Tian, J. W., L. P. Hu, X. Li, J. Geng, M. Dai, and X. Y. Bai. 2016. MicroRNA-130b promotes lung cancer progression via PPAR gamma/VEGF-A/BCL-2-mediated suppression of apoptosis. J. Exp. Clin. Cancer Res. 35:105. doi:10.1186/s13046-016-0444-6.
   PubMed Web of Science ®Google Scholar
• Wang, S., W. Wu, and F. X. Claret. 2017. Mutual regulation of microRNAs and DNA methylation in human cancers. Epigenetics 12:187–97. doi:10.1080/15592294.2016.1273308.
   PubMed Web of Science ®Google Scholar
• Yu, T., R. Cao, S. Li, M. Fu, L. Ren, W. Chen, H. Zhu, Q. Zhan, and R. Shi. 2015. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. BMC Cancer 15:29. doi:10.1186/s12885-015-1584-3.
   PubMed Web of Science ®Google Scholar
• Zare, M., M. Bastami, S. Solali, and M. R. Alivand. 2018. Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications. J. Cell Physiol. 233:3729–44. doi:10.1002/jcp.26116.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., B. Zhang, L. N. Sun, Q. N. Yan, Y. Zhang, Z. F. Zhang, Y. J. Su, and C. L. Wang. 2018. MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway. Cell Biochem. Funct. 36:194–202. doi:10.1002/cbf.3331.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Q. Yang, and S. Wang. 2014. MicroRNAs: A new key in lung cancer. Cancer Chemother. Pharmacol. 74:1105–11. doi:10.1007/s00280-014-2559-9.
   PubMed Web of Science ®Google Scholar